2003
DOI: 10.1016/s0272-2712(02)00066-5
|View full text |Cite
|
Sign up to set email alerts
|

Transmissible spongiform encephalopathy update and implications for blood safety

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2003
2003
2015
2015

Publication Types

Select...
4
1
1

Relationship

1
5

Authors

Journals

citations
Cited by 7 publications
(2 citation statements)
references
References 29 publications
0
2
0
Order By: Relevance
“…Although epidemiologic searches have not revealed any such transmissions to date, 8 the incubation period for acquired TSEs can be as long as 30 to 40 years, as has been shown for Kuru and iatrogenic CJD, and it is thus not yet possible to assess the eventual occurrence of blood‐related human‐to‐human transmissibility of vCJD.…”
mentioning
confidence: 99%
“…Although epidemiologic searches have not revealed any such transmissions to date, 8 the incubation period for acquired TSEs can be as long as 30 to 40 years, as has been shown for Kuru and iatrogenic CJD, and it is thus not yet possible to assess the eventual occurrence of blood‐related human‐to‐human transmissibility of vCJD.…”
mentioning
confidence: 99%
“…Each of the human forms of the prion disease has very distinct pathologies and symptoms. Whether inherited, transmitted, or sporadic in nature, PrP Sc from the brain of diseased individuals is infectious, and can be transmitted horizontally (Flechsig et al 2001;Hogan et al 1999;Ricketts and Brown 2003;Zobeley et al 1999) sporadic Creutzfeldt-Jakob disease (sCJD); iatrogenic Creutzfeldt-Jakob disease (iCJD); familial Creutzfeldt-Jakob disease (fCJD); variant Creutzfeldt-Jakob disease (vCJD); Gerstmann-Sträussler-Scheinker syndrome (GSS); sporadic Fatal Insomnia (sFI); familial Fatal Insomnia (fFI); Human Growth Hormone (HGH).…”
Section: Characterization Of Prion Diseasementioning
confidence: 99%